These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 2483028

  • 1. Neurodevelopmental impairment and deranged PRPP and purine nucleotide synthesis in inherited superactivity of PRPP synthetase.
    Becker MA, Puig JG, Mateos FA, Jimenez ML, Kim M, Simmonds HA.
    Adv Exp Med Biol; 1989; 253A():15-22. PubMed ID: 2483028
    [No Abstract] [Full Text] [Related]

  • 2. Increased purine nucleotide degradation in the central nervous system (CNS) in PRPP synthetase superactivity.
    Jiménez ML, Puig JG, Mateos FA, Ramos TH, Melián JS, Nieto VG, Becker MA.
    Adv Exp Med Biol; 1989; 253A():9-13. PubMed ID: 2560341
    [No Abstract] [Full Text] [Related]

  • 3. Mutant feedback-resistant phosphoribosylpyrophosphate synthetase associated with purine overproduction and gout. Phosphoribosylpyrophosphate and purine metabolism in cultured fibroblasts.
    Zoref E, De Vries A, Sperling O.
    J Clin Invest; 1975 Nov; 56(5):1093-9. PubMed ID: 171280
    [Abstract] [Full Text] [Related]

  • 4. PRPP and purine nucleotide metabolism in human lymphoblasts with both PRPP synthetase superactivity and HGPRT deficiency.
    Becker MA, Kim M, Husain K.
    Adv Exp Med Biol; 1989 Nov; 253B():13-20. PubMed ID: 2481968
    [No Abstract] [Full Text] [Related]

  • 5. Inherited superactivity of phosphoribosylpyrophosphate synthetase: association of uric acid overproduction and sensorineural deafness.
    Becker MA, Puig JG, Mateos FA, Jimenez ML, Kim M, Simmonds HA.
    Am J Med; 1988 Sep; 85(3):383-90. PubMed ID: 2843048
    [Abstract] [Full Text] [Related]

  • 6. [PRPP synthetase superactivity].
    Fujimori S.
    Nihon Rinsho; 1996 Dec; 54(12):3309-14. PubMed ID: 8976111
    [Abstract] [Full Text] [Related]

  • 7. Superactivity of human phosphoribosyl pyrophosphate synthetase due to altered regulation by nucleotide inhibitors and inorganic phosphate.
    Becker MA, Losman MJ, Wilson J, Simmonds HA.
    Biochim Biophys Acta; 1986 Jun 19; 882(2):168-76. PubMed ID: 2423135
    [Abstract] [Full Text] [Related]

  • 8. Superactive phosphoribosylpyrophosphate synthetase with altered regulatory and catalytic properties.
    Becker MA, Raivio KO, Bakay B, Adams WB, Nyhan WL.
    Adv Exp Med Biol; 1980 Jun 19; 122A():387-92. PubMed ID: 6158850
    [No Abstract] [Full Text] [Related]

  • 9. Gout with superactive phosphoribosylpyrophosphate synthetase due to increased enzyme catalytic rate.
    Becker MA, Losman MJ, Itkin P, Simkin PA.
    J Lab Clin Med; 1982 Apr 19; 99(4):495-511. PubMed ID: 6174658
    [Abstract] [Full Text] [Related]

  • 10. Patterns of phosphoribosylpyrophosphate and ribose-5-phosphate concentration and generation in fibroblasts from patients with gout and purine overproduction.
    Becker MA.
    J Clin Invest; 1976 Feb 19; 57(2):308-18. PubMed ID: 176178
    [Abstract] [Full Text] [Related]

  • 11. Phosphoribosylpyrophosphate synthesis in cultured human cells.
    Benke PJ, Dittmar D.
    Science; 1977 Dec 16; 198(4322):1171-3. PubMed ID: 201027
    [Abstract] [Full Text] [Related]

  • 12. PRPP synthetase superactivity in lymphoblast lines.
    Becker MA, Losman MJ, Rimon D, Kim M.
    Adv Exp Med Biol; 1986 Dec 16; 195 Pt A():51-8. PubMed ID: 3014839
    [No Abstract] [Full Text] [Related]

  • 13. [PRPP synthetase superactivity].
    Kawasugi K, Takeuchi F.
    Nihon Rinsho; 2003 Jan 16; 61 Suppl 1():284-7. PubMed ID: 12629732
    [No Abstract] [Full Text] [Related]

  • 14. Phosphoribosylpyrophosphate synthetase superactivity. A study of five patients with catalytic defects in the enzyme.
    Becker MA, Losman MJ, Rosenberg AL, Mehlman I, Levinson DJ, Holmes EW.
    Arthritis Rheum; 1986 Jul 16; 29(7):880-8. PubMed ID: 3017368
    [Abstract] [Full Text] [Related]

  • 15. Overproduction disease in man due to enzyme feedback resistance mutation. Purine overproduction in gout due to excessive activity of mutant feedback-resistant phosphoribosylpyrophosphate synthetase.
    Sperling O, Boer P, Brosh S, Zoref E, de Vries A.
    Enzyme; 1978 Jul 16; 23(1):1-9. PubMed ID: 203449
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Superactivity of phosphoribosylpyrophosphate synthetase, due to feedback resistance, causing purine overproduction and gout.
    Sperling O, Boer P, Brosh S, Zoref E, de Vries A.
    Ciba Found Symp; 1977 Jul 16; (48):143-64. PubMed ID: 204460
    [Abstract] [Full Text] [Related]

  • 18. Phosphoribosylpyrophosphate synthetase superactivity: detection, characterization of underlying defects, and treatment.
    Becker MA.
    Adv Exp Med Biol; 1984 Jul 16; 165 Pt A():91-96. PubMed ID: 6326492
    [No Abstract] [Full Text] [Related]

  • 19. [5-Phosphoribosyl-1-pyrophosphate synthetase overexpression].
    Kamatani N, Totokawa S.
    Ryoikibetsu Shokogun Shirizu; 1998 Jul 16; (18 Pt 1):432-4. PubMed ID: 9590092
    [No Abstract] [Full Text] [Related]

  • 20. Synthesis of phosphoribosylpyrophosphate in mammalian cells.
    Becker MA, Raivio KO, Seegmiller JE.
    Adv Enzymol Relat Areas Mol Biol; 1979 Jul 16; 49():281-306. PubMed ID: 95664
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.